With a looming decision on whether the #Federal#Reserve will #interest#rates (which I personally believe they should), many who were of the persuasion that the job market is “very strong,” have had to come to grips with significant #revisions to the jobs reports from the past year, and several months. Albeit the fact that I did not study #Computational#Biology in college, conceptually for me it was not at all difficult to think of which #computations would be useful for an entry level job that I had, for an extremely short period of time.
In this day and age, interest, along with #hiring#needs for #Computational#Biology has nearly depleted completely over the past few years. This harsh reality makes it all the more disappointing for #professionals like myself, as only people who have been in the field for several years can make use of their expertise. Several #Biotech companies, particularly in the #Pharma and #clinical#trials space, that used to invest in #Computational#Biology are not anymore.
Whether the broader #Biotechnology#industry will face a similar fate as the #Computational#Biologists will remains to be seen. Despite always trying to be as optimistic as possible myself, unfortunately I cannot imagine, long term, that there will be much of a difference as the industry is facing a #liquidity crisis. For years, #Biotech companies were able to secure very large amounts of funding based upon the **promise** of being able to leverage #high#throughput#screens. Ironically though, even with such #screens, #Synthetic#biology companies in particular (like #Ginkgo#Bioworks) are, contrary to their claims, removing #scientific personnel from their facilities as their #hiring needs have significantly slowed.
Pete Rigas
🤔 What has become of the #Computational #Biology #job #market?
With a looming decision on whether the #Federal #Reserve will #interest #rates (which I personally believe they should), many who were of the persuasion that the job market is “very strong,” have had to come to grips with significant #revisions to the jobs reports from the past year, and several months. Albeit the fact that I did not study #Computational #Biology in college, conceptually for me it was not at all difficult to think of which #computations would be useful for an entry level job that I had, for an extremely short period of time.
In this day and age, interest, along with #hiring #needs for #Computational #Biology has nearly depleted completely over the past few years. This harsh reality makes it all the more disappointing for #professionals like myself, as only people who have been in the field for several years can make use of their expertise. Several #Biotech companies, particularly in the #Pharma and #clinical #trials space, that used to invest in #Computational #Biology are not anymore.
Whether the broader #Biotechnology #industry will face a similar fate as the #Computational #Biologists will remains to be seen. Despite always trying to be as optimistic as possible myself, unfortunately I cannot imagine, long term, that there will be much of a difference as the industry is facing a #liquidity crisis. For years, #Biotech companies were able to secure very large amounts of funding based upon the **promise** of being able to leverage #high #throughput #screens. Ironically though, even with such #screens, #Synthetic #biology companies in particular (like #Ginkgo #Bioworks) are, contrary to their claims, removing #scientific personnel from their facilities as their #hiring needs have significantly slowed.
We need more #transparent #job #postings. The #economy has performed extremely poorly over the past year, especially due to downwards #revisions of 1 MILLION jobs. #Economists which unfortunately had a difficult time predicting the #2008 #crash need to address recent #jobs #revisions.
#opentowork #jobs #nojobs #ghost #jobs #bankruptcies #biotech #biotechnology #synbio #synthetic #biology #molecular #screens #insilico
2 weeks ago | [YT] | 1